Akorn appoints Douglas Boothe CEO
Akorn announced that Douglas Boothe has been named president and CEO, effective January 1, 2019. Most recently, Boothe served as the president of the generics division of Impax Laboratories.https://thefly.com/landingPageNews.php?id=2840377
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.